Pharma Focus Asia

Olon SpA acquires Capua BioServices SpA

Monday, January 28, 2019

Olon SpA, a global leader in pharmaceutical active substances (API), a company dedicated to manufacturing and development outsourcing (CDMO), and a supplier of generics, today announced the acquisition of Capua BioServices SpA , a global supplier of CDMO services in the field of microbial fermentation, as part of the continued expansion of its global presence.

Paolo Tubertini , CEO of Olon, said: "With the acquisition of Capua BioServices, Olon will have the opportunity to accelerate its growth by adding new CDMO projects and being recognized as the European leader in the CDMO sector. microbial fermentation (with a total fermentation capacity of 4,500 m3). This acquisition includes a world-class manufacturing facility and a dedicated team of experts that will help us deliver high quality services that meet or exceed customer expectations.

Following the acquisition of the Ricerca Biosciences chemical division in mid- 2017 and the Mahad (India) manufacturing site, announced in the third quarter of 2018 and completed in the first quarter of 2019, we have taken an additional step in our strategic plan . This acquisition enabled Olon to successfully complete its 3-year development plan. "

Capua BioServices is a global provider of quality services in the field of custom microbial process development and manufacturing. Capua BioServices offers dedicated solutions for protein, specialized small molecule and microorganism problems for applications in the pharmaceutical, food, feed and other bio-industrial markets. The site, which is beta-lactam-free and has a total fermentation capacity of approximately 1,400 m3, is located in Capua, near Naples.(southern Italy), and includes about 230 employees. Over the last 60 years, the company has developed a roadmap based on its long-standing experience working with a variety of bacterial, yeast and fungal systems. No impact on jobs is expected and Olon intends to invest in the site and pursue business development opportunities to optimize the operation of the plant and expand its customer base.

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024